We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Assured Guaranty
AGO
$3.35B
| $1.17M | ﹤0.01% |
13,004
+1,200
| +10% | +$105K |
|
902
Procept Biorobotics
PRCT
$1.26B
| $1.17M | ﹤0.01% |
14,500
-1,100
| -7% | -$94K |
|
903
White Mountains Insurance
WTM
$5.11B
| $1.17M | ﹤0.01% |
+600
| New | +$1.13M |
|
904
Euronet Worldwide
EEFT
$2.78B
| $1.17M | ﹤0.01% |
11,330
+1,500
| +15% | +$153K |
|
|
JBTM
905
JBT Marel
JBTM
$6.1B
| $1.16M | ﹤0.01% |
9,151
+1,300
| +17% | +$150K |
|
906
Shake Shack
SHAK
$2.98B
| $1.16M | ﹤0.01% |
8,900
+1,200
| +16% | +$147K |
|
907
Avnet
AVT
$7.87B
| $1.15M | ﹤0.01% |
22,000
-2,300
| -9% | -$125K |
|
908
Maximus
MMS
$2.94B
| $1.15M | ﹤0.01% |
15,416
+1,900
| +14% | +$155K |
|
909
Exponent
EXPO
$3.24B
| $1.15M | ﹤0.01% |
12,900
| – | – |
|
|
X
910
DELISTED
US Steel
X
| $1.15M | ﹤0.01% |
33,800
| – | – |
|
911
Power Integrations
POWI
$3.48B
| $1.15M | ﹤0.01% |
18,602
-1,600
| -8% | -$102K |
|
912
Ultragenyx Pharmaceutical
RARE
$2.6B
| $1.15M | ﹤0.01% |
27,223
+2,700
| +11% | +$134K |
|
913
Rayonier
RYN
$6.54B
| $1.14M | ﹤0.01% |
45,874
+750
| +2% | +$20.9K |
|
914
EPR Properties
EPR
$4.73B
| $1.13M | ﹤0.01% |
25,600
+2,200
| +9% | +$101K |
|
915
Lyft
LYFT
$6.48B
| $1.13M | ﹤0.01% |
87,600
+13,200
| +18% | +$196K |
|
916
Wayfair
W
$13.9B
| $1.13M | ﹤0.01% |
25,500
| – | – |
|
917
United Bankshares
UBSI
$6.68B
| $1.13M | ﹤0.01% |
30,046
+2,400
| +9% | +$94.5K |
|
918
ADMA Biologics
ADMA
$2.11B
| $1.13M | ﹤0.01% |
+65,700
| New | +$1.24M |
|
919
KB Home
KBH
$3.45B
| $1.12M | ﹤0.01% |
17,074
-5,000
| -23% | -$389K |
|
920
H.B. Fuller
FUL
$3.24B
| $1.12M | ﹤0.01% |
16,616
-400
| -2% | -$30K |
|
921
NovoCure
NVCR
$2.02B
| $1.12M | ﹤0.01% |
37,523
+3,300
| +10% | +$69.8K |
|
922
Crinetics Pharmaceuticals
CRNX
$8.96B
| $1.11M | ﹤0.01% |
21,800
+2,800
| +15% | +$157K |
|
923
Lincoln National
LNC
$8.67B
| $1.11M | ﹤0.01% |
34,900
+8,100
| +30% | +$270K |
|
924
Howard Hughes
HHH
$4.04B
| $1.1M | ﹤0.01% |
14,358
+1,000
| +7% | +$79.6K |
|
925
Hancock Whitney
HWC
$6.37B
| $1.1M | ﹤0.01% |
20,174
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.